235 related articles for article (PubMed ID: 32292164)
1. Antagonism of PP2A is an independent and conserved function of HIV-1 Vif and causes cell cycle arrest.
Marelli S; Williamson JC; Protasio AV; Naamati A; Greenwood EJ; Deane JE; Lehner PJ; Matheson NJ
Elife; 2020 Apr; 9():. PubMed ID: 32292164
[TBL] [Abstract][Full Text] [Related]
2. Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated Using Patient HIV-1 Isolates and Computational Modeling.
Salamango DJ; McCann JL; Demir Ö; Becker JT; Wang J; Lingappa JR; Temiz NA; Brown WL; Amaro RE; Harris RS
J Virol; 2020 Oct; 94(21):. PubMed ID: 32847850
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Vif Triggers Cell Cycle Arrest by Degrading Cellular PPP2R5 Phospho-regulators.
Salamango DJ; Ikeda T; Moghadasi SA; Wang J; McCann JL; Serebrenik AA; Ebrahimi D; Jarvis MC; Brown WL; Harris RS
Cell Rep; 2019 Oct; 29(5):1057-1065.e4. PubMed ID: 31665623
[TBL] [Abstract][Full Text] [Related]
4. Demystifying Cell Cycle Arrest by HIV-1 Vif.
Salamango DJ; Harris RS
Trends Microbiol; 2021 May; 29(5):381-384. PubMed ID: 33478820
[TBL] [Abstract][Full Text] [Related]
5. Critical role of PP2A-B56 family protein degradation in HIV-1 Vif mediated G2 cell cycle arrest.
Nagata K; Shindo K; Matsui Y; Shirakawa K; Takaori-Kondo A
Biochem Biophys Res Commun; 2020 Jun; 527(1):257-263. PubMed ID: 32446377
[TBL] [Abstract][Full Text] [Related]
6. Evolutionary Conservation of PP2A Antagonism and G2/M Cell Cycle Arrest in Maedi-Visna Virus Vif.
Luperchio AM; Jónsson SR; Salamango DJ
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016323
[TBL] [Abstract][Full Text] [Related]
7. Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.
Duan S; Yu X; Wang C; Meng L; Gai Y; Zhou Y; Gu T; Yu B; Wu J; Yu X
J Virol; 2022 Sep; 96(17):e0055522. PubMed ID: 35950859
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1.
Ikeda T; Shimizu R; Nasser H; Carpenter MA; Cheng AZ; Brown WL; Sauter D; Harris RS
mBio; 2023 Aug; 14(4):e0078223. PubMed ID: 37555667
[TBL] [Abstract][Full Text] [Related]
9. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into PPP2R5A degradation by HIV-1 Vif.
Hu Y; Delviks-Frankenberry KA; Wu C; Arizaga F; Pathak VK; Xiong Y
Nat Struct Mol Biol; 2024 May; ():. PubMed ID: 38789685
[TBL] [Abstract][Full Text] [Related]
11. Genetic and functional characterization of HIV-1 Vif on APOBEC3G degradation: First report of emergence of B/C recombinants from North India.
Ronsard L; Raja R; Panwar V; Saini S; Mohankumar K; Sridharan S; Padmapriya R; Chaudhuri S; Ramachandran VG; Banerjea AC
Sci Rep; 2015 Oct; 5():15438. PubMed ID: 26494109
[TBL] [Abstract][Full Text] [Related]
12. Temporal proteomic analysis of HIV infection reveals remodelling of the host phosphoproteome by lentiviral Vif variants.
Greenwood EJ; Matheson NJ; Wals K; van den Boomen DJ; Antrobus R; Williamson JC; Lehner PJ
Elife; 2016 Sep; 5():. PubMed ID: 27690223
[TBL] [Abstract][Full Text] [Related]
13. Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif.
Zhao K; Du J; Rui Y; Zheng W; Kang J; Hou J; Wang K; Zhang W; Simon VA; Yu XF
Cell Cycle; 2015; 14(6):838-47. PubMed ID: 25590520
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Vif's Capacity To Manipulate the Cell Cycle Is Species Specific.
Evans EL; Becker JT; Fricke SL; Patel K; Sherer NM
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321323
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Vif Gained Breadth in APOBEC3G Specificity after Cross-Species Transmission of Its Precursors.
Chesarino NM; Emerman M
J Virol; 2022 Feb; 96(4):e0207121. PubMed ID: 34908448
[TBL] [Abstract][Full Text] [Related]
16. A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.
Duan S; Wang S; Song Y; Gao N; Meng L; Gai Y; Zhang Y; Wang S; Wang C; Yu B; Wu J; Yu X
J Biol Chem; 2020 Oct; 295(43):14592-14605. PubMed ID: 32817167
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
[TBL] [Abstract][Full Text] [Related]
18. Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein.
Stupfler B; Verriez C; Gallois-Montbrun S; Marquet R; Paillart JC
Viruses; 2021 Apr; 13(4):. PubMed ID: 33916704
[TBL] [Abstract][Full Text] [Related]
19. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
Zhang W; Du J; Evans SL; Yu Y; Yu XF
Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
[TBL] [Abstract][Full Text] [Related]
20. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
